Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Rituximab 375 / Polatuzumab Vedotin 1.8 / Bendamustine 90, diffuse large B-non-Hodgkin Lymphoma, cycle 2-6

Protocol-ID: 1423 V1.1 (Mini), RITU375/POLVED1.8/BEND90, DLBCL, C2-6

Indication(s)

  • NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 22.06.2022